Form 4 for CUE Cue Biopharma, Inc.
Accepted 2023-08-29 00:00:00 ET · period of report 2023-08-25 · accession 0001209191-23-047575 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-08-29 | 2023-08-25 | CUE | Suri Anish | Pres AND CSO | P - Purchase | $2.76 | +4,000 | 135.6K | +3% | +$11.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-25 | P | A | 4,000 | $2.76 | 135,638 | D | — | — |